Traders Are Watching: Delta Air Lines, Inc. (NYSE:DAL), MacroGenics, Inc. (NASDAQ:MGNX), Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), Cleveland BioLabs, Inc. (NASDAQ:CBLI), KeyCorp. (NYSE:KEY)

Delta Air Lines, Inc. (NYSE:DAL) belongs to Services sector. Its net profit margin is 2.90% and weekly performance is 7.14%. On last trading day company shares ended up $43.37. Delta Air Lines, Inc. (NYSE:DAL) distance from 50-day simple moving average (SMA50) is 0.86%. On 25 June, it was reported Airline behemoth Delta Air Lines (NYSE:DAL) has inked a three-year sponsorship deal with Chelsea Football Club. However, financial terms of the transaction have not been revealed.

MacroGenics, Inc. (NASDAQ:MGNX) shares advanced 1.52% in last trading session and ended the day at $39.44. MGNX return on assets is 4.70%. MacroGenics, Inc. (NASDAQ:MGNX) quarterly performance is 13.40%. Roth Capital reiterated their buy rating on shares of MacroGenics (NASDAQ:MGNX) in a research note released on Wednesday morning, Market Beat reports.

On 13 July, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) shares advanced 62.56% and was closed at $3.69. OHRP EPS growth in last 5 year was -32.60%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) year to date (YTD) performance is -55.76%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), announced positive final results from a Phase II investigator sponsored clinical trial of OHR-102 (0.2% Squalamine lactate ophthalmic solution) in patients with macular edema secondary to branch (BRVO) and central retinal vein occlusion (CRVO).

Cleveland BioLabs, Inc. (NASDAQ:CBLI) ended the last trading day at $4.11. Company weekly volatility is calculated as 11.40% and price to cash ratio as 3.22. Cleveland BioLabs, Inc. (NASDAQ:CBLI) showed a weekly performance of 11.08%. Cleveland BioLabs, Inc. (NASDAQ:CBLI) announced the results of a Phase 1 single-blinded, randomized, placebo-controlled, healthy-subject study of CBLB612, an investigational drug in development for oncology indications, including the prevention of chemotherapy-induced myelosuppression.

KeyCorp. (NYSE:KEY) shares advanced 0.80% in last trading session and ended the day at $15.04. KEY return on assets is 0.90%. KeyCorp. (NYSE:KEY) quarterly performance is 6.08%.KeyCorp (NYSE: KEY) declared a quarterly dividend of $0.075 per share, or $0.3 annualized. The dividend will be payable on September 15, 2015, to stockholders of record on September 1, 2015, with an ex-dividend date of August 28, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *